Trump Administration Reaches Drug-Pricing Agreements with Major Pharma Firms Including Pfizer and AbbVie
The Trump administration has reached voluntary most-favored-nation (MFN) pricing agreements with 17 major pharmaceutical companies, including Pfizer, AbbVie, and Bristol Myers Squibb. These deals aim to align drug prices with those in other developed countries while expanding discounted purchasing options for consumers.
Topics: government regulation pharmaceutical industry pricing strategy